← Back to the idea

Intracellular 5-HT2AR Location-Bias Drug Screening Assay

A preclinical assay service that distinguishes between compounds activating cell-surface versus intracellular 5-HT2A receptors. This allows drug developers to isolate neuroplasticity-promoting effects from hallucinogenic activity, targeting a specific subcellular receptor pool.